About
Christopher Simms has served as 4DMT's Chief Commercial and Business Officer since December 2025, and served as Chief Commercial Officer from September 2024 until December 2025.
Mr. Simms previously served as Chief Commercial Officer at IVERIC bio, Inc. from August 2021 to July 2024. From November 2017 to July 2021, he served in various roles at Novartis AG, most recently as VP, Head of US Ophthalmics.
Mr. Simms holds an MBA degree from York University, Schulich School of Business, and a Bachelor of Commerce from Memorial University of Newfoundland.
Roles
4D Molecular Therapeutics, Inc.
Chief Commercial and Business Officer · Current role
2024–present
IVERIC bio, Inc.
Chief Commercial Officer · Chief Commercial Officer from August 2021 to July 2024.
2021-2024
Novartis AG
VP, Head of US Ophthalmics · Various roles from November 2017 to July 2021, most recently VP, Head of US Ophthalmics.
2017-2021
Also at 4D Molecular Therapeutics, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.